Clinical trials remain one of the most resource-intensive stages of drug development. Slow enrollment, protocol amendments, zero-enrollment sites, and incomplete real-world evidence can delay timelines and increase cost—ultimately slowing access to life-changing...
Today, we are excited to introduce Truveta Live Link, a breakthrough solution that transforms how life science organizations generate real-world evidence. Truveta Live Link unites a life sciences organization’s proprietary data and continuously updated real-world...
Today, Truveta was featured as #1 on LinkedIn’s Top Startups in Seattle for 2025 list. The ranking highlights ten growing start-up companies in the Seattle area. Last year, Truveta was ranked #3 on the inaugural Seattle list. Earlier this month, Truveta was also...
Medical device manufacturers and regulators face a persistent challenge: obtaining a complete, clinically rich view of how devices are used, how safe they are, and how they affect patient outcomes. Historically, researchers have been limited to claims, chargemaster,...
At Johns Hopkins University, the Hopkins Business of Health Initiative (HBHI) has launched the HBHI–Truveta User Community, dedicated to fostering a collaborative group of researchers who use Truveta Data to drive cutting-edge research in health and healthcare. Led by...
